{
    "nctId": "NCT04200482",
    "briefTitle": "Lifestyle Program (Scalable Nutrition and Physical Activity) for the Improvement of Nutrition and Physical Activity in Stage 0-III Breast Cancer Survivors",
    "officialTitle": "Testing a Scalable Nutrition and Physical Activity Program for Breast Cancer Survivors: A Dose-Finding Pilot Study",
    "overallStatus": "COMPLETED",
    "conditions": "Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8, Anatomic Stage IIB Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8, Anatomic Stage IIIC Breast Cancer AJCC v8, Prognostic Stage 0 Breast Cancer AJCC v8, Prognostic Stage I Breast Cancer AJCC v8, Prognostic Stage IA Breast Cancer AJCC v8, Prognostic Stage IB Breast Cancer AJCC v8, Prognostic Stage II Breast Cancer AJCC v8, Prognostic Stage IIA Breast Cancer AJCC v8, Prognostic Stage IIB Breast Cancer AJCC v8, Prognostic Stage III Breast Cancer AJCC v8, Prognostic Stage IIIA Breast Cancer AJCC v8, Prognostic Stage IIIB Breast Cancer AJCC v8, Prognostic Stage IIIC Breast Cancer AJCC v8",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "SUPPORTIVE_CARE",
    "enrollmentCount": 90,
    "primaryOutcomeMeasure": "Accrual rate",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Previous diagnosis of stage 0-III breast cancer in the past 10 years at the time of enrollment\n* No evidence of recurrent or metastatic disease\n* No uncontrolled diabetes mellitus defined as glycosylated hemoglobin (Hgb A1C) \\> 8%\n* No uncontrolled hypertension per Seattle Cancer Care Alliance (SCCA) standard of care\n* At least 60 days post final chemotherapy, biologic therapy, or radiation therapy and/or surgery. Current use of endocrine therapy is permitted (e.g., tamoxifen and aromatase inhibitors)\n* Access to phone for study contacts\n* Access to smartphone, tablet, or computer and internet to attend online session(s) and receive study electronic eHealth communication (text messages and access to website)\n* Willing and able to attend the online session(s) on Saturdays, or via online accessed videos, for up to 12 sessions in 6 months\n* Successfully complete all run-in activities, including at-home and over the phone assessments, 7 days of collecting physical activity data via accelerometer, and providing blood and stool sample\n* Willing and able to complete all study activities for 6 months after randomization\n* Participants must consume \\< 5 servings of fruits and vegetables per day and/or engage in \\< 150 minutes per week of moderate to vigorous physical activity, as assessed by brief questionnaires\n* Participants must have an Eastern Cooperative Oncology Group (ECOG) Scale of performance status score of 0 or 1 for performance status.\n* Signed physician approval for diet change and physical activity\n* Able to understand and willing to sign written informed electronic (e) consent in English\n\nExclusion Criteria:\n\n* Participants must not be active smokers within the past 30 days.\n* Women must not be pregnant at time of enrollment",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}